General Purpose
Active
ID: 1266887
·
First filed: Aug 4, 2004
Pharmaceutical Research and Manufacturers of America IEC
View
Receipt Summary
| Source Type | Distribution | Amount | Percentage |
|---|---|---|---|
| Other | $13M | 100.0% | |
| Individual | $1.9K | 0.0% | |
| Committee | $1.5K | 0.0% | |
| Total | $13M | 100% |
Receipts
| Donor | Total Amount | % of Total | |
|---|---|---|---|
|
Novartis Pharmaceuticals Corporation
Other
|
7.8% | ||
|
Amgen, Inc.
Other
|
7.1% | ||
|
Astellas Pharma Us, Inc.
Other
|
6.0% | ||
|
Eli Lilly and Company
Other
|
5.4% | ||
|
Merck & Co.
Other
|
4.8% | ||
|
Bristol-Myers Squibb Company
Other
|
4.5% | ||
|
Sanofi-Aventis
Other
|
4.3% | ||
|
Takeda Pharmaceuticals
Other
|
4.1% | ||
|
Johnson & Johnson Services Inc.
Other
|
3.7% | ||
|
Abbvie
Other
|
3.6% | ||
|
Bristol Myers Squibb Company
Other
|
3.3% | ||
|
Eli Lilly & Company
Other
|
3.3% | ||
|
Abbott Laboratories
Other
|
3.0% | ||
|
Lundbeck Inc.
Other
|
2.9% | ||
|
Glaxosmithkline
Other
|
2.8% | ||
|
Merck & Co. Inc
Other
|
2.6% | ||
|
Takeda Pharmaceuticals America Inc.
Other
|
2.5% | ||
|
Celgene Corporation
Other
|
2.0% | ||
|
Ucb, Inc.
Other
|
1.8% | ||
|
Genentech, Inc.
Other
|
1.8% | ||
|
Genetech, Inc.
Other
|
1.6% | ||
|
Daiichi Sankyo, Inc.
Other
|
1.6% | ||
|
Pfizer Inc.
Other
|
1.6% | ||
|
Neurocrine Biosciences
Other
|
1.4% | ||
|
Otsuka
Other
|
1.4% |